// STATE LEGISLATION TRACKER

Kansas SB 497 — Adding kratom to schedule I of the uniform controlled substances act and making conforming amendments to the definition

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Unknown

State: Kansas
Bill: SB 497
Session: 2025-2026
Filed: 2026-02-06
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Kansas SB497 appears to target kratom by adding it to schedule I of the uniform controlled substances act and making a conforming fentanyl-related definition change. Based on the title and subjects provided, it does not appear to regulate compounded peptides, off-label prescribing, telehealth, naturopathic or NP scope, or FDA 503A/503B compounding.

Key Points

No apparent change to peptide prescribing or access
No apparent change to 503A or 503B peptide compounding
Kratom would be treated as a schedule I controlled substance
Clinicians should watch only if they also advise on kratom use

What to Watch For

Note The bill is controlled-substance focused, not peptide-focused, based on the available title and subjects.

Concern If enacted, kratom access could be restricted, but that does not directly affect peptide therapy.

Note No recorded actions were provided, so the bill's procedural posture is unclear.

Where the Bill Stands

The source information says no actions are recorded, so there is not enough process history to classify the bill beyond unknown.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws